New York, USA – December 20, 2022 – As one of the leading chemical manufacturers and suppliers globally, Alfa Chemistry is well-prepared to provide a number of active pharmaceutical ingredients (APIs), such as donepezil and dexmedetomidine hydrochloride, for customers worldwide ranging from lab to commercial scale. Earlier this month, the company announced that three other APIs had been introduced for its global customers as well, namely, lenalidomide, parecoxib sodium, and rivaroxaban.
Pfizer's Dynastat (parecoxib sodium) Receives Approval in Europe
List of centrally authorised products requiring a notification of a change for update of annexes